Impact of risk assessment and tailored versus non-tailored risk information on colorectal cancer testing in primary care: A randomized controlled trial

Celette Sugg Skinner, Ethan A. Halm, Wendy Pechero Bishop, Chul Ahn, Samir Gupta, David Farrell, Jay Morrow, Manjula Julka, Katharine McCallister, Joanne M. Sanders, Emily Marks, Susan M. Rawl

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Colorectal cancer screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations. Methods: Randomized controlled trial among patients who: (i) used CRIS and they and their physicians received tailored printouts; (ii) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for colorectal cancer screening; or (iii) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months. Results: Participation in any colorectal cancer testing was three times higher for those who used the CRIS and received any printed materials, compared with no-contact controls (47% vs. 16%; P < 0.0001).Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53% vs. 44%, P=0.023). Conclusion: Use of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than non-tailored group. Impact: Asking patients questions about their specific risk factors and giving them and their providers information just prior to an appointment may increase participation in colorectal cancer testing. Tailoring the information has some added benefit.

Original languageEnglish (US)
Pages (from-to)1523-1530
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume24
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Colorectal Neoplasms
Primary Health Care
Randomized Controlled Trials
Neoplasms
Early Detection of Cancer
Physicians
Appointments and Schedules
Guidelines
Electronic Health Records
Tablets

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Impact of risk assessment and tailored versus non-tailored risk information on colorectal cancer testing in primary care : A randomized controlled trial. / Skinner, Celette Sugg; Halm, Ethan A.; Bishop, Wendy Pechero; Ahn, Chul; Gupta, Samir; Farrell, David; Morrow, Jay; Julka, Manjula; McCallister, Katharine; Sanders, Joanne M.; Marks, Emily; Rawl, Susan M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 24, No. 10, 01.10.2015, p. 1523-1530.

Research output: Contribution to journalArticle

Skinner, Celette Sugg ; Halm, Ethan A. ; Bishop, Wendy Pechero ; Ahn, Chul ; Gupta, Samir ; Farrell, David ; Morrow, Jay ; Julka, Manjula ; McCallister, Katharine ; Sanders, Joanne M. ; Marks, Emily ; Rawl, Susan M. / Impact of risk assessment and tailored versus non-tailored risk information on colorectal cancer testing in primary care : A randomized controlled trial. In: Cancer Epidemiology Biomarkers and Prevention. 2015 ; Vol. 24, No. 10. pp. 1523-1530.
@article{30c1b047750b4c369d8d88abc28eb443,
title = "Impact of risk assessment and tailored versus non-tailored risk information on colorectal cancer testing in primary care: A randomized controlled trial",
abstract = "Background: Colorectal cancer screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations. Methods: Randomized controlled trial among patients who: (i) used CRIS and they and their physicians received tailored printouts; (ii) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for colorectal cancer screening; or (iii) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months. Results: Participation in any colorectal cancer testing was three times higher for those who used the CRIS and received any printed materials, compared with no-contact controls (47{\%} vs. 16{\%}; P < 0.0001).Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53{\%} vs. 44{\%}, P=0.023). Conclusion: Use of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than non-tailored group. Impact: Asking patients questions about their specific risk factors and giving them and their providers information just prior to an appointment may increase participation in colorectal cancer testing. Tailoring the information has some added benefit.",
author = "Skinner, {Celette Sugg} and Halm, {Ethan A.} and Bishop, {Wendy Pechero} and Chul Ahn and Samir Gupta and David Farrell and Jay Morrow and Manjula Julka and Katharine McCallister and Sanders, {Joanne M.} and Emily Marks and Rawl, {Susan M.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1158/1055-9965.EPI-15-0122",
language = "English (US)",
volume = "24",
pages = "1523--1530",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Impact of risk assessment and tailored versus non-tailored risk information on colorectal cancer testing in primary care

T2 - A randomized controlled trial

AU - Skinner, Celette Sugg

AU - Halm, Ethan A.

AU - Bishop, Wendy Pechero

AU - Ahn, Chul

AU - Gupta, Samir

AU - Farrell, David

AU - Morrow, Jay

AU - Julka, Manjula

AU - McCallister, Katharine

AU - Sanders, Joanne M.

AU - Marks, Emily

AU - Rawl, Susan M.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Colorectal cancer screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations. Methods: Randomized controlled trial among patients who: (i) used CRIS and they and their physicians received tailored printouts; (ii) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for colorectal cancer screening; or (iii) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months. Results: Participation in any colorectal cancer testing was three times higher for those who used the CRIS and received any printed materials, compared with no-contact controls (47% vs. 16%; P < 0.0001).Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53% vs. 44%, P=0.023). Conclusion: Use of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than non-tailored group. Impact: Asking patients questions about their specific risk factors and giving them and their providers information just prior to an appointment may increase participation in colorectal cancer testing. Tailoring the information has some added benefit.

AB - Background: Colorectal cancer screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations. Methods: Randomized controlled trial among patients who: (i) used CRIS and they and their physicians received tailored printouts; (ii) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for colorectal cancer screening; or (iii) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months. Results: Participation in any colorectal cancer testing was three times higher for those who used the CRIS and received any printed materials, compared with no-contact controls (47% vs. 16%; P < 0.0001).Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53% vs. 44%, P=0.023). Conclusion: Use of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than non-tailored group. Impact: Asking patients questions about their specific risk factors and giving them and their providers information just prior to an appointment may increase participation in colorectal cancer testing. Tailoring the information has some added benefit.

UR - http://www.scopus.com/inward/record.url?scp=84942863329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942863329&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-15-0122

DO - 10.1158/1055-9965.EPI-15-0122

M3 - Article

C2 - 26265201

AN - SCOPUS:84942863329

VL - 24

SP - 1523

EP - 1530

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 10

ER -